tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

ImmunoGen downgraded to Equal Weight from Overweight at Barclays

Barclays downgraded ImmunoGen (IMGN) to Equal Weight from Overweight after the company agreed to be acquired by AbbVie (ABBV) for $31.26 per share in cash.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on IMGN:

Disclaimer & DisclosureReport an Issue

1